NO984233L - Cytokine called Larch-8 - Google Patents

Cytokine called Larch-8

Info

Publication number
NO984233L
NO984233L NO984233A NO984233A NO984233L NO 984233 L NO984233 L NO 984233L NO 984233 A NO984233 A NO 984233A NO 984233 A NO984233 A NO 984233A NO 984233 L NO984233 L NO 984233L
Authority
NO
Norway
Prior art keywords
lerk
larch
cytokine called
called
cytokine
Prior art date
Application number
NO984233A
Other languages
Norwegian (no)
Other versions
NO984233D0 (en
Inventor
Douglas P Cerretti
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of NO984233D0 publication Critical patent/NO984233D0/en
Publication of NO984233L publication Critical patent/NO984233L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Abstract

Oppfinnelsen er rettet mot et protein kalt Lerk-8, DNA som koder for Lerk-8, og vertsceller transformert med Lerk-8-DNA. Antistoffer som er immunreaktive med Lerk-8 er også tilveiebragt. Lerk-8-proteinet binder til celleoverflatereseptorene kjent som elk og hek.The invention is directed to a protein called Lerk-8, DNA encoding Lerk-8, and host cells transformed with Lerk-8 DNA. Antibodies that are immunoreactive with Lerk-8 are also provided. The Lerk-8 protein binds to the cell surface receptors known as elk and witch.

NO984233A 1996-03-21 1998-09-14 Cytokine called Larch-8 NO984233L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62114696A 1996-03-21 1996-03-21
PCT/US1997/004533 WO1997036919A2 (en) 1996-03-21 1997-03-19 Cytokine designated lerk-8

Publications (2)

Publication Number Publication Date
NO984233D0 NO984233D0 (en) 1998-09-14
NO984233L true NO984233L (en) 1998-11-23

Family

ID=24488927

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984233A NO984233L (en) 1996-03-21 1998-09-14 Cytokine called Larch-8

Country Status (7)

Country Link
EP (1) EP0904287A3 (en)
JP (1) JP2001521368A (en)
KR (1) KR19990087793A (en)
AU (1) AU2538697A (en)
IL (1) IL125919A0 (en)
NO (1) NO984233L (en)
WO (1) WO1997036919A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842272A4 (en) * 1995-07-20 2002-03-06 Amrad Operations Pty Ltd Novel receptor ligands and genetic sequences encoding same
US6602683B1 (en) * 1995-10-25 2003-08-05 Regeneron Pharmaceuticals, Inc. Biologically active Eph family ligands
WO2004028551A1 (en) 2002-09-24 2004-04-08 The Burnham Institute Novel agents that modulate eph receptor activity
CA2595892A1 (en) 2005-01-27 2006-08-03 The Burnham Institute Ephb receptor-binding peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303769B1 (en) * 1994-07-08 2001-10-16 Immunex Corporation Lerk-5 dna
EP0785716B1 (en) * 1994-10-05 2006-11-29 Immunex Corporation Cytokine designated lerk-6
PT871702E (en) * 1994-12-06 2005-10-31 Immunex Corp DESIGNATED CYTOKIN LERK-7

Also Published As

Publication number Publication date
KR19990087793A (en) 1999-12-27
WO1997036919A2 (en) 1997-10-09
NO984233D0 (en) 1998-09-14
EP0904287A3 (en) 2000-12-20
AU2538697A (en) 1997-10-22
IL125919A0 (en) 1999-04-11
EP0904287A2 (en) 1999-03-31
JP2001521368A (en) 2001-11-06
WO1997036919A3 (en) 2000-10-12

Similar Documents

Publication Publication Date Title
FI972390A (en) Cytokine called Lerk-7
NO965627D0 (en) New cytokine designated larch-5
ATE353906T1 (en) CD27 LIGAND
FI960743A0 (en) Cytokines that bind to the cell surface witch receptor
DE68916423D1 (en) ENZYMATICALLY REINFORCED, PIEZOELECTRICAL, SPECIFIC BINDING TEST.
NO976045D0 (en) Cytokine that induces apoptosis
DK189090A (en) PROTEINS THAT PROMOTE IMMUNOLOGICAL EFFECT CELL ACTIVATION AND CHEMISTRY
DK0669929T3 (en) Elk ligand, a cytokine
NO970740L (en) Glutamate receptor
DE68928834D1 (en) MONOCLONAL ANTIBODIES AGAINST CAT T-LYMPHOTROPES LENTIVIRUS
NO882054L (en) CEMENT MIXTURE, SPECIFIC FOR USE IN BOREHOLES.
NO984233L (en) Cytokine called Larch-8
DE3485219D1 (en) TGF POLYPEPTIDES, DERIVATIVE ANTIGEN OLIGOPEPTIDES, ANTIBODIES OBTAINED THEREOF.
ES2178203T3 (en) METHODS AND REAGENTS TO MODULATE APOPTOSIS.
DE3686799T2 (en) FOR DIPTERY LARVES TOXIC POLYPEPTIDES.
BG103627A (en) New ifn receptor 1-binding proteins, dna encoding them, and methods for the modulation of a cellular response for interferons
ATE408687T1 (en) SEMAPHORINE POLYPEPTIDES
BR0315222A (en) Promoter of il-18bp, its preparation and use
DK459588D0 (en) SORTING CONSTRUCTION FOR YOU
MX9701904A (en) Novel pka-binding proteins and uses thereof.
BRPI0216042B8 (en) polypeptide capable of binding to ang-2, expression vector, host cell, pharmaceutical composition, and use of said polypeptides.
MX9700213A (en) Novel cytokine designated lerk-5
ATE105291T1 (en) SPIRO-ISOCHINOLINE-PYRROLIDINE-TETRONS AND ANALOGUES THEREOF, USABLE AS ALDOSE REDUCTASE INHIBITORS.